BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 17, 2000
View Archived Issues
FDA approves novel assay for the diagnosis and management of alcohol abuse
Read More
Collateral Therapeutics boosts cardiovascular gene therapy portfolio with new patent
Read More
P&U will market Novo Nordisk's HRT products in U.S.
Read More
Isis and AstraZeneca establish antisense target validation program
Read More
Oxford BioMedica acquires novel antibody technology
Read More
Preparation, use and pharmaceutical compositions of new Galderma compounds
Read More
Kinase-inhibitory antiproliferative indolones in development at Boehringer Ingelheim
Read More
New Merck carbapenems with activity against methicillin-resistant staphylococci
Read More
New antioxidants from ADIR particularly useful for treating oxidative stress in the CNS
Read More
Porphyrin-based agents for PDT and MRI designed at Schering AG
Read More
Vertex patents heterocyclic p38 MAP kinase inhibitors and their use
Read More
Chinese-Thai collaboration will study traditional herbal remedies for AIDS and cancer
Read More
Previously unstudied tropical plant yields novel anti-HIV peptides
Read More
Skandigen announces name change
Read More
JAK3 identified as a new target for the treatment of ALS
Read More
Successful oral delivery of calcitonin reported by Novartis
Read More
Naltriben: potential new pharmacotherapeutic for reducing alcohol intake
Read More
Nippon Kayaku devotes significant resources to the fight against cancer
Read More
New anti-HIV compounds available for licensing from NIH
Read More
Matrix completes patient enrollment in pivotal head and neck cancer trials
Read More
Details behind formation of global leader in pharmaceuticals --Glaxo SmithKline-- released
Read More
European Commission approves new indication for AstraZeneca antiasthmatic
Read More
UCB acquires Fujirebio, thereby expanding UCB Japan
Read More
Apollo's neuroprotective vitamin D compounds covered by U.S. patent
Read More
Isolation of unnamed tick-borne bacterium causing HGE patented by Aquila
Read More
CpG ImmunoPharmaceuticals changes name
Read More
Four-year results from Early Postmenopausal Intervention Cohort Study presented
Read More